| Literature DB >> 34221667 |
Lorenzo Cortese1,2, Giuseppe Lo Presti1,2, Marta Zanoletti3, Gloria Aranda4, Mauro Buttafava5, Davide Contini3, Alberto Dalla Mora3, Hamid Dehghani6, Laura Di Sieno3, Sixte de Fraguier7, Felicia A Hanzu4,8,9, Mireia Mora Porta4,8,9, An Nguyen-Dinh10, Marco Renna5,11, Bogdan Rosinski10, Mattia Squarcia4,12, Alberto Tosi5, Udo M Weigel13, Stanislaw Wojtkiewicz6, Turgut Durduran1,14.
Abstract
We present the LUCA device, a multi-modal platform combining eight-wavelength near infrared time resolved spectroscopy, sixteen-channel diffuse correlation spectroscopy and a clinical ultrasound in a single device. By simultaneously measuring the tissue hemodynamics and performing ultrasound imaging, this platform aims to tackle the low specificity and sensitivity of the current thyroid cancer diagnosis techniques, improving the screening of thyroid nodules. Here, we show a detailed description of the device, components and modules. Furthermore, we show the device tests performed through well established protocols for phantom validation, and the performance assessment for in vivo. The characterization tests demonstrate that LUCA device is capable of performing high quality measurements, with a precision in determining in vivo tissue optical and dynamic properties of better than 3%, and a reproducibility of better than 10% after ultrasound-guided probe repositioning, even with low photon count-rates, making it suitable for a wide variety of clinical applications.Entities:
Year: 2021 PMID: 34221667 PMCID: PMC8221941 DOI: 10.1364/BOE.416561
Source DB: PubMed Journal: Biomed Opt Express ISSN: 2156-7085 Impact factor: 3.732